Damascus claims France involved in staging Khan Sheikhoun chemical attackWorld April 27, 12:23
Russian Investigative Committee denies Tu-154 crashed in Sochi due to overloadWorld April 27, 12:12
Russian intelligence chief doubts Trump’s election pledges to fight terrorism 'sincere'Russian Politics & Diplomacy April 27, 11:11
Foreign intelligence chief says current ideological standoff worse than Cold War eraRussian Politics & Diplomacy April 27, 11:10
Russian diplomat believes Western obsession with Assad leads to dead endRussian Politics & Diplomacy April 27, 10:30
Maria Sharapova wins first match after disqualificationSport April 27, 9:38
Abe expects progress in talks on peace treaty with RussiaWorld April 27, 9:06
Media: Israeli Air Force strike hits area near Damascus airportWorld April 27, 8:35
Russian diplomat believes US strikes on Syria make no military or political senseRussian Politics & Diplomacy April 27, 8:30
MOSCOW, October 29. /TASS/. The Federal Antimonopoly Service (FAS) wants to introduce a simplified procedure for admission of medicines, previously registered in the US and Europe to Russia, the head of FAS Igor Artemyev said on Thursday speaking at a cabinet session.
"It is necessary to check the history [of these medicines]. This system should not be automatic, we have to check, but if it was registered in the United States or Europe, there must be a simplified procedure for the introduction of these medicines in the Russian Federation," he said.
Artemyev also said that in the next five years a new section for the development of competition in the healthcare sector should be added to the competition development program.
"It is necessary to add an aspect about the sale of medicines via retail chains there. I would say that the issue of substitution should be solved not by 2018 but by 2017. This will have a significant effect on prices and improve competition in healthcare sector," he said.